SARS-CoV-2 NSP13 Antibodies
SARS-CoV-2 Nonstructural Protein 13 (NSP13) is one of the sixteen nonstructural proteins of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19. SARS-CoV-2 NSP13 has a theoretical molecular weight of 66.9 kDa and is suggested to have helicase activity and unwinds RNA, which is enhanced by its interaction with NSP12. NSP13 is also involved in several biological processes including transcriptional regulation, Golgi organization, protein kinase A signaling, and centrosome complex formation. Browse our catalog of rabbit polyclonal SARS-CoV-2 NSP13 antibodies. Validated research applications for SARS-CoV-2 NSP13 antibodies include ELISA and Western Blot. Choose the viral-specific anti-SARS-CoV-2 NSP13 antibody that is best suited for your research needs by viewing the technical details and related products. Our SARS-CoV-2 NSP13 antibodies are fully covered by Novus’ Guarantee+.
Alternate Names for SARS-CoV-2 NSP13 Antibodies
anti-helicase antibody, anti-Non-structural protein 13 antibody
6 Results for "sars-cov-2-nsp13" in Primary Antibodies
![Immunohistochemistry: SARS-CoV-2 nsp13 Antibody [NBP3-07055] - Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 (COVID-19) NSP13 antibody (0.5 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 degrees celsius. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 NSP13 protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung.](http://images.novusbio.com/fullsize/SARS-CoV-2-nsp13-Antibody-Immunohistochemistry-NBP3-07055-img0001.jpg "Immunohistochemistry: SARS-CoV-2 nsp13 Antibody [NBP3-07055] - Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 (COVID-19) NSP13 antibody (0.5 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 degrees celsius. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 NSP13 protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung.")
![ELISA: SARS-CoV-2 nsp13 Antibody [NBP3-07055] - Antibodies: SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody. A direct ELISA was performed using SARS-CoV-2 NSP13 recombinant protein (10-427) as coating antigen and the anti-SARS-CoV-2 (COVID-19) NSP13 (Helicase) antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 1 ng/mL to 3000 ng/mL.](http://images.novusbio.com/fullsize/SARS-CoV-2-nsp13-Antibody-ELISA-NBP3-07055-img0002.jpg)
![SARS-CoV-2 nsp13 Antibody [NBP3-07055] - Antibodies: SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody. A direct ELISA was performed using immunogen peptide (9181P) as coating antigen and the anti-SARS-CoV-2 (COVID-19) NSP13 (Helicase) antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 0.3 ng/mL to 1000 ng/mL.](http://images.novusbio.com/fullsize/SARS-CoV-2-nsp13-Antibody-NBP3-07055-img0003.jpg)
![Immunohistochemistry: SARS-CoV-2 nsp13 Antibody [NBP3-07056] - Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 (COVID-19) NSP13 antibody ( 0.5 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 degrees celsius. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 NSP13 protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung.](http://images.novusbio.com/fullsize/SARS-CoV-2-nsp13-Antibody-Immunohistochemistry-NBP3-07056-img0001.jpg "Immunohistochemistry: SARS-CoV-2 nsp13 Antibody [NBP3-07056] - Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 (COVID-19) NSP13 antibody ( 0.5 ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 degrees celsius. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 NSP13 protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung.")
![ELISA: SARS-CoV-2 nsp13 Antibody [NBP3-07056] - Antibodies: SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody. A direct ELISA was performed using SARS-CoV-2 NSP13 recombinant protein as coating antigen and the anti-SARS-CoV-2 (COVID-19) NSP13 (Helicase) antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 1 ng/mL to 3000 ng/mL.](http://images.novusbio.com/fullsize/SARS-CoV-2-nsp13-Antibody-ELISA-NBP3-07056-img0002.jpg)
![Western Blot: SARS-CoV-2 nsp13 Antibody [NBP3-07964] - Various lysates were subjected to SDS-PAGE followed by western blot with SARS-CoV-2 (2019-nCoV) Nsp13 Protein antibody at dilution of 1:1000.](http://images.novusbio.com/fullsize/SARS-CoV-2-nsp13-Antibody-Western-Blot-NBP3-07964-img0001.jpg "Western Blot: SARS-CoV-2 nsp13 Antibody [NBP3-07964] - Various lysates were subjected to SDS-PAGE followed by western blot with SARS-CoV-2 (2019-nCoV) Nsp13 Protein antibody at dilution of 1:1000.")